Role of S-adenosylhomocysteine hydrolase in adenosine-induced apoptosis in HepG2 cells

Experimental Cell Research

Volumn 313, Issue 2, 2007, Pages 264-283

  Hermes, Marina ^a   Osswald, Hartmut ^a   Kloor, Doris ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Adenosine receptors; AMP activated kinase; Caspase activation; Gene expression; HepG2 cells; mRNA methylation; p53; S Adenosylhomocysteine hydrolase

Indexed keywords

ADENOSINE DEAMINASE INHIBITOR; ADENOSINE DIALDEHYDE; ADENOSINE RECEPTOR; ADENOSYLHOMOCYSTEINASE; CASPASE; DIPYRIDAMOLE; DNA FRAGMENT; MESSENGER RNA; PENTOSTATIN; PROTEIN P53;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 33845996886     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.10.003     Document Type: Article

References (85)

1. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
2. Vallon V., Muehlbauer B., and Osswald H. Adenosine and kidney function. Physiol. Rev. 86 (2006) 901-940
3. Barry C.P., and Lind S.E. Adenosine-mediated killing of cultured epithelial cancer cells. Cancer Res. 60 (2000) 1887-1894
4. Ethier M.F., Chander V., and Dobson Jr. J.G. Adenosine stimulates proliferation of human endothelial cells in culture. Am. J. Physiol. 265 (1993) H131-H138
5. Dawicki D.D., Chatterjee D., Wyche J., and Rounds S. Extracellular ATP and adenosine cause apoptosis of pulmonary artery endothelial cells. Am. J. Physiol. 273 (1997) L485-L494
6. Harrington E.O., Smeglin A., Parks N., Newton J., and Rounds S. Adenosine induces endothelial apoptosis by activating protein tyrosine phosphatase: a possible role of p38alpha. Am. J. Physiol. 279 (2000) L733-L742
7. Rounds S., Yee W.L., Dawicki D.D., Harrington E., Parks N., and Cutaia M.V. Mechanism of extracellular ATP- and adenosine-induced apoptosis of cultured pulmonary artery endothelial cells. Am. J. Physiol. 275 (1998) L379-L388
8. Saitoh M., Nagai K., Nakagawa K., Yamamura T., Yamamoto S., and Nishizaki T. Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. Biochem. Pharmacol. 67 (2004) 2005-2011
9. Wen L.T., and Knowles A.F. Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor. Br. J. Pharmacol. 140 (2003) 1009-1018
10. Zhao Z., Kapoian T., Shepard M., and Lianos E.A. Adenosine-induced apoptosis in glomerular mesangial cells. Kidney Int. 61 (2002) 1276-1285
11. Fishman P., Bar-Yehuda S., and Vagman L. Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth. Cancer Res. 58 (1998) 3181-3187
12. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedebergs Arch. Pharmacol. 362 (2000) 299-309
13. Chow S.C., Kass G.E., and Orrenius S. Purines and their roles in apoptosis. Neuropharmacology 36 (1997) 1149-1156
14. Kloor D., Delabar U., Muehlbauer B., Luippold G., and Osswald H. Tissue levels of S-adenosylhomocysteine in the rat kidney: effects of ischemia and homocysteine. Biochem. Pharmacol. 63 (2002) 809-815
15. Blay J., White T.D., and Hoskin D.W. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res. 57 (1997) 2602-2605
16. Fredholm B.B., IJzerman A.P., Jacobson K.A., Klotz K.N., and Linden J. International union of pharmacology: XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53 (2001) 527-552
17. Kohno Y., Sei Y., Koshiba M., Kim H.O., and Jacobson K.A. Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists. Biochem. Biophys. Res. Commun. 219 (1996) 904-910
18. Di Iorio P., Kleywegt S., Ciccarelli R., Traversa U., Andrew C.M., Crocker C.E., Werstiuk E.S., and Rathbone M.P. Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Glia 38 (2002) 179-190
19. Shneyvays V., Nawrath H., Jacobson K.A., and Shainberg A. Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist. Exp. Cell Res. 243 (1998) 383-397
20. Hue L., Beauloye C., Bertrand L., Horman S., Krause U., Marsin A.S., Meisse D., Vertommen D., and Rider M.H. New targets of AMP-activated protein kinase. Biochem. Soc. Trans. 31 (2003) 213-215
21. Cantoni G.L., and Scarano E. The formation of S-adenosylhomocysteine in enzymatic transmethylation reactions. J. Am. Chem. Soc. 76 (1954) 4744
22. Cantoni G., and Chiang P. The role of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in the control of biological methylations. In: Cavalli D., Gaull G.E., and Zappia V. (Eds). Natural Sulfur Compounds: Novel Biochemical and Structural Aspects (1980), Plenum Press, New York 67-80
23. Clarke S., and Banfield K. S-Adenosylmethionine-dependent methyltransferases. In: Carmel R., and Jacobsen D. (Eds). Homocysteine in Health and Disease (2001), University Press, Cambridge 63-78
24. de la Haba G., and Cantoni G. The enzymatic synthesis of S-adenosyl-l-homocysteine from adenosine and homocysteine. J. Biol. Chem. 234 (1959) 606-608
25. Hoffman D.R., Marion D.W., Cornatzer W.E., and Duerre J.A. S-Adenosylmethionine and S-adenosylhomocysteine metabolism in isolated rat liver. Effects of l-methionine, l-homocysteine, and adenosine. J. Biol. Chem. 255 (1980) 10822-10827
26. Kloor D., Kurz J., Fuchs S., Faust B., and Osswald H. S-Adenosylhomocysteine-hydrolase from bovine kidney: enzymatic and binding properties. Kidney Blood Press. Res. 19 (1996) 100-108
27. Hermes M., Osswald H., Mattar J., and Kloor D. Influence of an altered methylation potential on mRNA methylation and gene expression in HepG2 cells. Exp. Cell Res. 294 (2004) 325-334
28. Kramer D.L., Porter C.W., Borchardt R.T., and Sufrin J.R. Combined modulation of S-adenosylmethionine biosynthesis and S-adenosylhomocysteine metabolism enhances inhibition of nucleic acid methylation and L1210 cell growth. Cancer Res. 50 (1990) 3838-3842
29. Kramer K., Harrington E.O., Lu Q., Bellas R., Newton J., Sheahan K.L., and Rounds S. Isoprenylcysteine carboxyl methyltransferase activity modulates endothelial cell apoptosis. Mol. Biol. Cell 14 (2003) 848-857
30. Perna A.F., Ingrosso D., De Santo N.G., Galletti P., and Zappia V. Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia. Kidney Int. 47 (1995) 247-253
31. Yi P., Melnyk S., Pogribna M., Pogribny I.P., Hine R.J., and James S.J. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 275 (2000) 29318-29323
32. Schwerk C., and Schulze-Osthoff K. Methyltransferase inhibition induces p53-dependent apoptosis and a novel form of cell death. Oncogene 24 (2005) 7002-7011
33. Aden D., Fogel A., Plotkin S., Damjanov I., and Knowles B. Controlled synthesis of HbsAg in a differentiated human liver carcinoma-derived cell line. Nature 282 (1979) 615-616
34. Knowles B.B., Howe C.C., and Aden D.P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209 (1980) 497-499
35. Neumeister B., Faigle M., Lauber K., Northoff H., and Wesselborg S. Legionella pneumophila induces apoptosis via the mitochondrial death pathway. Microbiology 148 (2002) 3639-3650
36. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
37. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
38. Delabar U., Kloor D., Luippold G., and Muehlbauer B. Simultaneous determination of adenosine, S-adenosylhomocysteine and S-adenosylmethionine in biological samples using solid-phase extraction and high-performance liquid chromatography. J. Chromatogr., B, Biomed. Sci. Appl. 724 (1999) 231-238
39. Hermes M., Hippel von S., Osswald H., and Kloor D. S-Adenosylhomocysteine metabolism in different cell lines: effect of hypoxia and cell density. Cell. Physiol. Biochem. 15 (2005) 233-244
40. Christofi F.L., Zhang H., Yu J.G., Guzman J., Xue J., Kim M., Wang Y.Z., and Cooke H.J. Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system. J. Comp. Neurol. 439 (2001) 46-64
41. Lu J., Pierron A., and Ravid K. An adenosine analogue, IB-MECA, down-regulates estrogen receptor {alpha} and suppresses human breast cancer cell proliferation. Cancer Res. 63 (2003) 6413-6423
42. Hermes M., Osswald H., and Kloor D. Adenosine metabolism and its effect on methylation potential in cultured cells: methodological considerations. Cell. Mol. Biol. 52 (2006) 53-59
43. Endresen P.C., Eide T.J., and Aarbakke J. Cell death initiated by 3-deazaadenosine in HL-60 cells is apoptosis and is partially inhibited by homocysteine. Biochem. Pharmacol. 46 (1993) 1893-1901
44. Earnshaw W.C., Martins L.M., and Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68 (1999) 383-424
45. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
46. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., and Dixit V.M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273 (1998) 2926-2930
47. Slee E.A., Adrain C., and Martin S.J. Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ. 6 (1999) 1067-1074
48. Cecconi F. Apaf1 and the apoptotic machinery. Cell Death Differ. 6 (1999) 1087-1098
49. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., and Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
50. Harrington E.O., Smeglin A., Newton J., Ballard G., and Rounds S. Protein tyrosine phosphatase-dependent proteolysis of focal adhesion complexes in endothelial cell apoptosis. Am. J. Physiol. 280 (2001) L342-L353
51. Sola A., Alfaro V., Vinas J.L., and Hotter G. Exogenous adenosine enhances caspase-3 activity in warm renal ischaemia. Pflugers Arch. 447 (2004) 387-391
52. 6-benzyladenosine-5′-uronamides enhances selectivity for A3 adenosine receptors. J. Med. Chem. 37 (1994) 3614-3621
53. Kim Y.C., Ji X.D., and Jacobson K.A. Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype. J. Med. Chem. 39 (1996) 4142-4148
54. Mueller C.E. A(3) adenosine receptor antagonists. Mini Rev. Med. Chem. 1 (2001) 417-427
55. Kim S.G., Ravi G., Hoffmann C., Jung Y.J., Kim M., Chen A., and Jacobson K.A. p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA. Biochem. Pharmacol. 63 (2002) 871-880
56. Kohno Y., Sei Y., Koshiba M., Kim H.O., and Jacobson K.A. Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists. Biochem. Biophys. Res. Commun. 219 (1996) 904-910
57. Schrier S.M., van Tilburg E.W., van der Meulen H., Ijzerman A.P., Mulder G.J., and Nagelkerke J.F. Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells: studies on involvement of adenosine receptors and adenosine uptake. Biochem. Pharmacol. 61 (2001) 417-425
58. Chiang P.K., Gordon R.K., Tal J., Zeng G.C., Doctor B.P., Pardhasaradhi K., and McCann P.P. S-Adenosylmethionine and methylation. FASEB J. 10 (1996) 471-480
59. Ueland P.M. Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol. Rev. 34 (1982) 223-253
60. Ramakrishnan V., and Borchardt R. Adenosine dialdehyde and neplanocin A: potent inhibitors of S-adenosylhomocysteine hydrolase in neuroblastoma N2a cells. Neurochem. Int. 10 (1987) 423-431
61. Cory J.G., and Mansell M.M. Studies on mammalian ribonucleotide reductase inhibition by pyridoxal phosphate and the dialdehyde derivates of adenosine, adenosine 5′-monophosphate, and adenosine 5′ triphosphate. Cancer Res. 35 (1975) 390-396
62. Chiang P.K., Richards H.H., and Cantoni G.L. S-Adenosyl-l-homocysteine hydrolase: analogues of S-adenosyl-l-homocysteine as potential inhibitors. Mol. Pharmacol. 13 (1977) 939-947
63. Guranowski A., Montgomery J.A., Cantoni G.L., and Chiang P.K. Adenosine analogues as substrates and inhibitors of S-adenosylhomocysteine hydrolase. Biochemistry 20 (1981) 110-115
64. Dillman R.O. Pentostatin (Nipent) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia. Expert Rev. Anticancer Ther. 4 (2004) 27-36
65. Giannecchini M., D'Innocenzo B., Pesi R., Sgarrella F., Iorio M., Collecchi P., Tozzi M.G., and Camici M. 2′-Deoxyadenosine causes apoptotic cell death in a human colon carcinoma cell line. J. Biochem. Mol. Toxicol. 17 (2003) 329-337
66. Kim H.S., Jeong S.Y., Lee J.H., Kim B.E., Kim J.W., Jeong S.W., and Kim I.K. Induction of apoptosis in human leukemia cells by 3-deazaadenosine is mediated by caspase-3-like activity. Exp. Mol. Med. 32 (2000) 197-203
67. Schatz R.A., Wilens T.E., and Sellinger O.Z. Decreased transmethylation of biogenic amines after in vivo elevation of brain S-adenosyl-l-homocysteine. J. Neurochem. 36 (1981) 1739-1748
68. Jacob R.A., Gretz D.M., Taylor P.C., James S.J., Pogribny I.P., Miller B.J., Henning S.M., and Swendseid M.E. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J. Nutr. 128 (1998) 1204-1212
69. Rampersaud G.C., Kauwell G.P., Hutson A.D., Cerda J.J., and Bailey L.B. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am. J. Clin. Nutr. 72 (2000) 998-1003
70. Karpf A.R., Moore B.C., Ririe T.O., and Jones D.A. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-Aza-2′-deoxycytidine. Mol. Pharmacol. 59 (2001) 751-757
71. Schneider-Stock R., Diab-Assef M., Rohrbeck A., Foltzer-Jourdainne C., Boltze C., Hartig R., Schonfeld P., Roessner A., and Gali-Muhtasib H. 5-aza-Cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms. J. Pharmacol. Exp. Ther. 312 (2005) 525-536
72. Jackson-Grusby L., Beard C., Possemato R., Tudor M., Fambrough D., Csankovszki G., Dausman J., Lee P., Wilson C., Lander E., and Jaenisch R. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat. Genet. 27 (2001) 31-39
73. Stancheva I., Hensey C., and Meehan R.R. Loss of the maintenance methyltransferase, xDnmt1, induces apoptosis in Xenopus embryos. EMBO J. 20 (2001) 1963-1973
74. Radomski N., Kaufmann C., and Dreyer C. Nuclear accumulation of S-adenosylhomocysteine hydrolase in transcriptionally active cells during development of Xenopus laevis. Mol. Biol. Cell 10 (1999) 4283-4298
75. Radomski N., Barreto G., Kaufmann C., Yokoska J., Mizumoto K., and Dreyer C. Interaction of S-adenosylhomocysteine hydrolase of Xenopus laevis with mRNA(guanine-7-)methyltransferase: implication on its nuclear compartmentalisation and on cap methylation of hnRNA. Biochim. Biophys. Acta 1590 (2002) 93-102
76. Picksley S.M., and Lane D.P. The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53?. BioEssays 15 (1993) 689-690
77. Chen J., Lin J., and Levine A.J. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol. Med. 1 (1995) 142-152
78. Haupt Y., Maya R., Kazaz A., and Oren M. Mdm2 promotes the rapid degradation of p53. Nature 387 (1997) 296-299
79. Kubbutat M.H., Jones S.N., and Vousden K.H. Regulation of p53 stability by Mdm2. Nature 387 (1997) 299-303
80. Johnston J.B., Daeninck P., Verburg L., Lee K., Williams G., Israels L.G., Mowat M.R., and Begleiter A. p53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia. Leuk. Lymphoma 26 (1997) 435-449
81. Hosono S., Lee C.S., Chou M.J., Yang C.S., and Shih C.H. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines. Oncogene 6 (1991) 237-243
82. Baric I., Fumic K., Glenn B., Cuk M., Schulze A., Finkelstein J.D., James S.J., Mejaski-Bosnjak V., Pazanin L., Pogribny I.P., Rados M., Sarnavka V., Scukanec-Spoljar M., Allen R.H., Stabler S., Uzelac L., Vugrek O., Wagner C., Zeisel S., and Mudd S.H. S-Adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc. Natl. Acad. Sci. 101 (2004) 4234-4239
83. Longnecker D.S. Abnormal methyl metabolism in pancreatic toxicity and diabetes. J. Nutr. 132 (2002) 2373-2376
84. Sigalas I., Calvert A.H., Anderson J.J., Neal D.E., and Lunec J. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nat. Med. 2 (1996) 912-917
85. Broackes-Carter F.C., Mouchel N., Gill D., Hyde S., Bassett J., and Harris A. Temporal regulation of CFTR expression during ovine lung development: implications for CF gene therapy. Hum. Mol. Genet. 11 (2002) 125-131